Headquartered in Winnipeg, Canada, Kane Biotech Inc. is a biotechnology firm established in 2001, focusing on the research, development, and global commercialization of innovative technologies and products engineered to prevent and remove microbial biofilms. The company's diverse portfolio features pet dental hygiene solutions marketed as StrixNB and bluestem, alongside DispersinB for both animal and human wound care. They also provide Alosera brand shampoos for dogs, cats, and horses, and Aledex for medical device coatings. Additional offerings include DermaKB scalp care products, Coactiv+ wound care items, and other specialized products under the goldstem, silkstem, and DermaKB Biofilm brand names.
Subscribe to see Kane Biotech Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kane Biotech Inc. is a biotech company headquartered in Winnipeg, Canada. It is publicly listed (KNE) with a market capitalisation of $4.4M. Xcout tracks 6 named people at Kane Biotech Inc., including Dr. Robert Huizinga (Interim Chief Executive Officer).
A few of Kane Biotech Inc.'s closest competitors — see the full list of competitors and alternatives →
Bioniche Life Sciences Inc. was a Canadian biopharmaceutical company focused on developing and commercializing products for human and animal health. It served healthcare providers, patients, livestock producers, veterinarians, and the agricultural industry through pharmaceuticals, vaccines, and related biological products.
Deltamune is a world-class biotechnology company headquartered in Centurion, South Africa, focusing on veterinary, animal health, and public health solutions including specialized vaccines.
Phoenix Animal Wellness, Inc. is a biotechnology company that leverages conserved stress-biology pathways to develop solutions for animal health, human therapeutics, and consumer wellness. The company serves the animal and human health sectors through its stress-biology platform.
Axitan Holdings is a biotechnology company that develops novel endolysin-based products to target and neutralize pathogenic bacteria for the animal protein and food safety industries. Its technology provides antibiotic-free solutions to help reduce antimicrobial resistance and address key productivity issues in poultry and livestock production.
Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. The company offers vaccines for pigs, poultry, and pets, as well as diagnostic reagents. Wuhan Keqian Biology Co.,Ltd was founded in 2001 and is based in Wuhan, China.
ZIVO Bioscience, Inc. is a research and development firm that specializes in the creation and commercialization of natural bioactive compounds. These unique ingredients, derived from its proprietary algae cultures, are licensed and sold to manufacturers producing goods for animal health, human consumption, dietary supplements, and medical foods. The company operates at the intersection of biotechnology and agricultural technology, boasting a comprehensive intellectual property portfolio. This includes distinct algal and bacterial strains, advanced biologically active molecules and complexes, innovative production and cultivation techniques, and various inventions, some patented and others pending approval, all geared towards improving human and animal well-being. Its product applications are broad, addressing areas such as promoting gut health in poultry, combating bovine mastitis, improving joint function in canines, modulating the human immune system, providing algal biomass for direct human consumption, and offering biomass-based solutions for skin care and anti-aging. Founded originally as Health Enhancement Products, Inc., the company officially rebranded to ZIVO Bioscience, Inc. in October 2014. Its corporate operations are based in Bloomfield Hills, Michigan.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.